CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 114 filers reported holding CULLINAN ONCOLOGY INC in Q1 2024. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,072,457 | -85.5% | 176,173 | -85.8% | 0.10% | -85.9% |
| Q1 2024 | $21,144,340 | +67.2% | 1,240,865 | 0.0% | 0.68% | +46.8% |
| Q4 2023 | $12,644,414 | -26.8% | 1,240,865 | -35.0% | 0.46% | -15.0% |
| Q3 2023 | $17,275,228 | -15.9% | 1,908,865 | 0.0% | 0.55% | -18.6% |
| Q2 2023 | $20,539,387 | – | 1,908,865 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $80,689,227 | 20.93% |
| CHI Advisors LLC | 3,317,544 | $35,000,089 | 9.32% |
| Nextech Invest Ltd. | 1,221,145 | $12,883,080 | 5.12% |
| BVF INC/IL | 7,509,059 | $79,220,572 | 3.34% |
| TANG CAPITAL MANAGEMENT LLC | 809,231 | $8,537,387 | 1.24% |
| SVB FINANCIAL GROUP | 27,032 | $285,188 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,416 | $2,420,339 | 0.69% |
| Boxer Capital, LLC | 1,074,082 | $11,331,565 | 0.60% |
| Atom Investors LP | 107,193 | $1,130,886 | 0.56% |
| HighVista Strategies LLC | 79,918 | $843,135 | 0.50% |